ABI Model Definitions for Critical Illness Cover: What They Mean for Your Policy

Critical illness insurance is purchased on the understanding that if you are diagnosed with a serious condition, the insurer will pay a lump sum. What is less widely understood is that the insurer does not pay on the basis of a clinical diagnosis alone. They pay only if your condition meets the specific, technical definition written into your policy.

The Association of British Insurers (ABI) has developed model definitions for the core critical illness conditions. These definitions set a baseline standard across the market, but individual insurers can — and do — diverge from them, both by offering more generous definitions and by imposing stricter criteria.

Understanding the ABI model definitions, and knowing where your policy diverges from them, is the difference between a policyholder who claims with confidence and one who is surprised to find their claim is declined.

The Purpose of the ABI Model Definitions

The ABI introduced model definitions for critical illness conditions in response to widespread consumer confusion about what CI policies actually covered. In the absence of standardised definitions, every insurer used different criteria for the same condition — making comparison between policies almost impossible and leading to claim disputes when policyholders believed they had met a condition but the insurer disagreed.

The model definitions are voluntary guidance, not legislation. Insurers can depart from them — and many do, in both directions. The value of the ABI model definitions is as a reference point: a benchmark against which you can assess whether a specific insurer's definition is more or less generous than the industry standard.

The Core Conditions: What the ABI Defines

The ABI model addresses seven core conditions that appear in virtually all CI policies. These are:

1. Cancer

The ABI model definition of cancer covers malignant tumours characterised by the uncontrolled growth and spread of malignant cells with invasion and destruction of normal tissue, histologically confirmed.

Key exclusions under the ABI model:

• Non-invasive cancers (carcinoma in situ) and other pre-malignant or borderline tumours
• Non-melanoma skin cancers (squamous cell carcinoma, basal cell carcinoma) unless they have spread
• Early-stage prostate cancer below the specified Gleason score and TNM staging threshold

What the ABI model does not specify clearly (leaving scope for insurers to deviate):

• Early-stage prostate cancer (e.g. Gleason score ≤6, T1N0M0): some insurers follow the ABI; others apply stricter criteria requiring a higher Gleason score or more advanced staging before paying out
• DCIS (ductal carcinoma in situ) of the breast: the ABI model does not definitively classify DCIS as cancer for CI purposes — it is not "invasive" in the conventional oncological sense; many policies exclude DCIS from the main cancer benefit (though it may trigger an "additional payment" at 25%)

The cancer definition is the single most important definition to scrutinise when selecting a CI policy. Cancer accounts for approximately 60% of all CI claims, and the distinctions within the cancer definition affect a very large number of real-world claims.

2. Heart Attack (Myocardial Infarction of Specified Severity)

The ABI model definition for heart attack requires evidence of all of the following:

• Typical clinical symptoms (chest pain)
• New and significant ECG changes consistent with myocardial infarction
• Elevation of cardiac enzymes or cardiac troponin above the normal laboratory reference range

This "of specified severity" qualification is critical. A patient who presents with chest pain and elevated troponin but without the "new and significant ECG changes" required may not meet the definition — even if their cardiologist clinically diagnoses a myocardial infarction.

Where definitions diverge: Some insurers specify minimum enzyme threshold levels (e.g. troponin must exceed a specified multiple of the upper reference range). Others do not specify thresholds beyond "above normal laboratory reference range". The threshold specification can affect whether a borderline cardiac event triggers a claim.

3. Stroke (Resulting in Permanent Symptoms)

The ABI model definition covers cerebrovascular accidents with infarction of brain tissue, intracranial or subarachnoid haemorrhage, or embolisation from an extracranial source resulting in permanent neurological deficit with persisting clinical symptoms.

Key qualification: The stroke must result in permanent neurological deficit with persisting clinical symptoms. A TIA (transient ischaemic attack) — sometimes called a "mini-stroke" — does not qualify because it does not (by definition) produce permanent deficit. A stroke that produces temporary neurological impairment that fully resolves within a few weeks does not qualify.

The duration requirement for "permanent" or "persisting" varies between insurers: some require symptoms persisting for 24 hours; others for three months; others for six months. This matters because modern medical treatment can achieve good recovery from strokes — but the policy may require persistent symptoms that are not always present after successful treatment.

4. Kidney Failure (Requiring Dialysis or Transplant)

The ABI model covers chronic, irreversible failure of both kidneys to function, requiring either regular dialysis or kidney transplantation. The requirement for dialysis or transplant is the key qualifier — early-stage chronic kidney disease (CKD) that is managed medically without dialysis does not trigger a claim.

This definition is relatively consistent across the market. The primary variation is whether the insurer covers conditions that lead to kidney failure (e.g. end-stage diabetic nephropathy) without separately naming them — which they all do, since the definition is based on function (kidneys have failed) rather than cause.

5. Major Organ Transplant

The ABI model covers the actual surgery to transplant any of heart, lung, liver, pancreas, small bowel, or bone marrow. Waiting list status alone does not trigger the benefit — the surgery must have taken place.

Some insurers also cover kidney transplant separately, though kidney failure requiring transplant is already covered under the kidney failure definition. Check for any overlap or gap in how your policy handles kidney transplant.

6. Coronary Artery Bypass Grafting (CABG)

The ABI model covers the actual surgery to correct narrowing or blockage of one or more coronary arteries with bypass grafts. Angioplasty (balloon treatment) or stenting — which treat the same narrowing non-surgically — are typically not covered by the ABI model definition.

The distinction matters clinically. Modern cardiology is moving away from bypass surgery toward less invasive interventions (angioplasty, stenting, drug-eluting stents). A patient who needs coronary intervention but is treated with angioplasty rather than bypass surgery will not trigger the CABG benefit, even though their underlying condition is equally serious. Some enhanced policies add "heart surgery requiring open chest" or "coronary angioplasty" as additional covered conditions to address this gap.

7. Multiple Sclerosis

The ABI model covers definite diagnosis of MS with clinical evidence of persisting clinical impairment of motor or sensory function. The requirement for persisting impairment distinguishes MS from an early relapsing-remitting diagnosis where the patient is currently symptom-free.

The qualification creates an anomaly: a patient with a confirmed MS diagnosis who is currently in remission (no active symptoms) may not immediately trigger the benefit. The policy will pay when the clinical impairment persists — which may not be from the date of diagnosis.

Beyond the Core: Additional Conditions

Most CI policies cover far more than the seven ABI core conditions. The "enhanced" market standard typically includes 40–60 additional conditions, which may include:

• Parkinson's disease
• Motor neurone disease
• Terminal illness (separate from CI — pays if life expectancy is less than 12 months)
• Loss of limbs
• Loss of sight, hearing, or speech
• Permanent total disability
• Alzheimer's disease and other forms of dementia (at specified severity)
• Traumatic head injury
• Aortic surgery
• Heart valve replacement or repair
• Third-degree burns over specified body area percentage
• Benign brain tumour requiring surgery

The breadth of the additional conditions list is a secondary indicator of CI policy quality after the definitions for the core conditions. A policy with 60 defined conditions is not necessarily superior to one with 40 — if the additional 20 conditions use stricter definitions than the core 40, the headline number is misleading.

The "Additional Payment" Tier: Partial Benefits for Less Severe Conditions

Modern CI policies frequently include a second tier of benefits — "additional payments" or "partial payments" — that pay a percentage of the main sum assured (typically 25% or 50%) for conditions that are serious but do not meet the full definition threshold.

Common additional payment conditions include:

• DCIS of the breast (25% of sum assured, subject to a maximum typically around £25,000)
• Carcinoma in situ of specified organs
• Early prostate cancer (T1N0M0, Gleason 6 or below)
• Low-grade bladder cancer
• Certain cardiac arrhythmias requiring device implantation (pacemaker)

The additional payment tier addresses the gap between "normal" and "full CI benefit" — conditions that are diagnosed and treated but do not meet the full ABI threshold. For cancer, where early detection is increasingly common, these provisions are practically valuable.

Critically, in most modern structures, the additional payment does not reduce the main sum assured. If you receive a 25% additional payment for DCIS, your full sum assured remains available for a subsequent full CI claim (subject to any policy conditions on the same diagnosis).

ABI+ and Enhanced Definitions

The term "ABI+" or "enhanced definition" is used by some insurers to indicate that their policy goes beyond the ABI model standard. Areas where enhanced definitions typically improve on the ABI model:

• Broader cancer definition (covering DCIS and early prostate cancer at full benefit or generous additional payment)
• Lower cardiac enzyme threshold for heart attack (covering less severe cardiac events)
• Shorter "persisting symptoms" requirement for stroke
• Additional cardiac conditions (heart valve surgery, aortic surgery)
• Broader neurological coverage (earlier-stage Alzheimer's, cognitive impairment)

When comparing CI policies, reviewing the specific definition wording — not just the condition list — is essential. Two policies that both claim to cover "cancer" may have materially different cancer definitions.

The Claims Statistics: What They Tell You

Major UK life and CI insurers publish annual claims statistics. Key data points from recent years (with variations between insurers):

• Overall CI claim acceptance rates: Typically 90–93%, meaning 7–10% of CI claims are declined
• Cancer claims as a percentage of all paid claims: Approximately 55–65%
• Heart attack claims: Approximately 12–17%
• Stroke claims: Approximately 8–12%

The most common reason for declined claims is that the condition does not meet the policy definition as stated — not fraud or non-disclosure. This underlines the importance of understanding the specific definitions before a claim arises.

How to Use This Knowledge When Selecting a Policy

1. Read the cancer definition. Check whether DCIS and early prostate cancer are covered, and at what level.
2. Check the heart attack definition. What cardiac enzyme threshold is specified?
3. Check the stroke definition. How long must symptoms persist before "permanent" is established?
4. Count the additional payment conditions. What is paid for less severe diagnoses?
5. Compare definitions, not just condition lists. A longer list does not guarantee better cover.
6. Ask for a summary of recent claims. Reputable insurers publish this data. It reveals which conditions generate most claims and the acceptance rate.

How Global Investments Can Help

Global Investments advises internationally mobile high net worth clients on critical illness cover selection and structure — including reviewing existing policies against ABI model standards and recommending enhanced-definition alternatives where appropriate.

We can also advise on international CI options for expatriates who require cover that is not restricted to UK-based treatment and UK-standard definitions.

Important: Critical illness policy definitions, condition lists, and payment structures change regularly. This guide reflects general market practice as of 2026 and does not constitute financial advice. Policies differ materially between insurers. Before arranging or switching CI cover, review the specific policy terms and seek independent financial advice.

---

Global Investments provides wealth management and protection planning services to internationally mobile individuals. Contact our advisers for a confidential discussion about your critical illness cover needs.